Proclara Biosciences IPO

Developer of disease-modifying therapies intended to be used for the treatment of neurodegenerative diseases. The company's therapies develop novel therapies that recognize and target multiple misfolded proteins, enabling clinicians to make a transformative impact on the lives of patients affected by Alzheimer's, Parkinson's and systemic amyloidosis.

Register for Details

For more details on financing and valuation for Proclara Biosciences, register or login.

Please provide a valid email address.

By registering, you agree to Forge’s Terms of Use. Already registered? Log in

What is Proclara Biosciences's ticker symbol?

Proclara Biosciences does not currently have an official ticker symbol because this company is still private. Register today to connect with our Private Market Specialists and learn more about new pre-IPO investment opportunities.

What is Proclara Biosciences's stock price?

The stock price for Proclara Biosciences will be known as it becomes public. Here are similar public companies: HealthStream (NAS: HSTM), Doximity (NYS: DOCS), Zymergen (NAS: ZY), Sight Sciences (NAS: SGHT).

Proclara Biosciences Funding Rounds and IPO Valuation

Date Funding Round Funding Raised Price per Share IPO Valuation
11/7/2018 Series F $6.92MM raised $XXX.XX $XXX.XX
9/7/2016 Series E $48.04MM raised $XXX.XX $XXX.XX
1/14/2015 Series D $57.82MM raised $XXX.XX $XXX.XX
Based on primary financings
Powered by Forge Data

Learn more about Proclara Biosciences

Forge green plus iconForge green minus icon

What is Proclara Biosciences funding to date?

Proclara Biosciences has raised $112.79MM to date.
Forge green plus iconForge green minus icon

When was Proclara Biosciences founded?

Proclara Biosciences was founded in 2006.
Forge green plus iconForge green minus icon

Can you invest in Proclara Biosciences?

Proclara Biosciences is a privately held company and is not publicly traded on NYSE or NASDAQ in the U.S. To buy pre-IPO shares of a private company, you need to be an accredited investor. Learn more about how to invest in the private market or register today to get started.

Forge green plus iconForge green minus icon

Can you sell Proclara Biosciences share pre-IPO?

If you own Proclara Biosciences pre-IPO shares and are considering selling, you can find what your shares could be worth on Forge’s secondary marketplace.

Our Private Market Specialists are available to answer any questions you might have and can help connect you with a buyer from our network of 125,000 accredited investors and institutions. You can also learn more about how to sell your private shares before getting started.

Forge green plus iconForge green minus icon

Is Proclara Biosciences a publicly traded company?

Proclara Biosciences is a private company and not publicly traded.

If you are interested in buying or selling private company shares, you can register with Forge today for free to explore your options. Registering gives you access to one of our Private Market Specialists who can guide you through the process of buying or selling. Learn more about how Forge might help you buy pre-IPO shares or sell pre-IPO shares.

Other companies like Proclara Biosciences in the Healthcare sector

Sector
Last Round Est. Valuation
$3.45B
Sector
Last Round Est. Valuation
$656.14MM
Sector
Last Round Est. Valuation
$3.67B
Sector
Last Round Est. Valuation
$705.25MM
Sector
Last Round Est. Valuation
$1.15B
Sector
Last Round Est. Valuation
$1.22B
Sector
Last Round Est. Valuation
$8.45B
Sector
Last Round Est. Valuation
$500MM
Updated on: Jun 12, 2022